BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

860 related articles for article (PubMed ID: 24781355)

  • 1. Correlation of biochemical markers and HCV RNA titers with fibrosis stages and grades in chronic HCV-3a patients.
    Shahid M; Idrees M; Nasir B; Raja AJ; Raza SM; Amin I; Rasul A; Tayyab GU
    Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):788-94. PubMed ID: 24781355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Aspartate aminotransferase (AST) more than alanine aminotransferase (ALT) levels predict the progression of liver fibrosis in chronic HCV infection].
    Stránský J; Ryzlová M; Striteský J; Horák J
    Vnitr Lek; 2002 Oct; 48(10):924-8. PubMed ID: 16737138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between histological findings, aminotransferase levels and viral genotype in chronic hepatitis C infection.
    Fecury AA; Almeida MK; Santos KN; Freitas Ada S; Dantas Sde F; Costa CA; Crescente ÂB; Sousa RC; Brito EB; Nassiri R; Lampe E; Martins LC
    Rev Soc Bras Med Trop; 2014; 47(1):90-2. PubMed ID: 24553802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
    Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
    Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relation of ALT and AST levels to the histopathological changes in liver biopsies of patients with chronic hepatitis C genotype 4.
    Khattab H; Fouad A; Hamza M; Mohey MA; El-Akel W; Ghoneim H; Abul-Fotouh A; Esmat G
    Arab J Gastroenterol; 2015 Jun; 16(2):50-3. PubMed ID: 26184441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical, biochemical and pathological profiles of 5464 Egyptian chronic hepatitis C-infected patients.
    Mabrouk M; El-Raziky M; Zayed N; Salama R; El-Akel W; Awad T; El Beshlawy M; Esmat G
    Hepatogastroenterology; 2013 Oct; 60(127):1731-5. PubMed ID: 24634943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus (HCV) infection and cryoglobulinemia: analysis of whole blood and plasma HCV-RNA concentrations and correlation with liver histology.
    Schmidt WN; Stapleton JT; LaBrecque DR; Mitros FA; Kirby PA; Phillips MJ; Brashear DL
    Hepatology; 2000 Mar; 31(3):737-44. PubMed ID: 10706566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
    Sheth SG; Flamm SL; Gordon FD; Chopra S
    Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship of histologic activity to serum ALT, HCV genotype and HCV RNA titers in chronic hepatitis C.
    Lee YS; Yoon SK; Chung ES; Bae SH; Choi JY; Han JY; Chung KW; Sun HS; Kim BS; Kim BK
    J Korean Med Sci; 2001 Oct; 16(5):585-91. PubMed ID: 11641527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninvasive assessment of hepatic fibrosis in Egyptian patients with chronic hepatitis C virus infection.
    Fouad SA; Esmat S; Omran D; Rashid L; Kobaisi MH
    World J Gastroenterol; 2012 Jun; 18(23):2988-94. PubMed ID: 22736923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum markers for necroinflammatory activity in patients with chronic viral hepatitis and normal or mildly elevated aminotransferase levels.
    Cheong JY; Kim DJ; Hwang SG; Yang JM; Kim YB; Park YN; Cho SW
    Liver Int; 2011 Oct; 31(9):1352-8. PubMed ID: 21745311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-histological assessment of liver fibrosis in HCV infection.
    Mangoud AM; Sanad SM; Hendawy A; el-Hady G; el-Sherbiny GT
    J Egypt Soc Parasitol; 2004 Aug; 34(2):383-95. PubMed ID: 15287165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Documented rapid course of hepatic fibrosis between two biopsies in patients coinfected by HIV and HCV despite high CD4 cell count.
    Bonnard P; Lescure FX; Amiel C; Guiard-Schmid JB; Callard P; Gharakhanian S; Pialoux G
    J Viral Hepat; 2007 Nov; 14(11):806-11. PubMed ID: 17927617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is serum alanine transaminase level a reliable marker of histological disease in chronic hepatitis C infection?
    Sanai FM; Benmousa A; Al-Hussaini H; Ashraf S; Alhafi O; Abdo AA; Alameri HF; Akbar HO; Bzeizi KI
    Liver Int; 2008 Aug; 28(7):1011-8. PubMed ID: 18384520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic accuracy of the Forns index, platelet count and AST to Platelet Ratio Index derived fibrosis index for the prediction of Hepatitis C virus-related significant liver fibrosis and cirrhosis.
    Kayadibi H; Yasar B; Ozkara S; Serdar MA; Kurdas OO; Gonen C
    Scand J Clin Lab Invest; 2014 Apr; 74(3):240-7. PubMed ID: 24460024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C: the role of serum aspartate transaminase in the evaluation of disease progression.
    Zechini B; Pasquazzi C; Aceti A
    Eur J Gastroenterol Hepatol; 2004 Sep; 16(9):891-6. PubMed ID: 15316414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
    Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
    Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.